Answers are grounded in this paper and cite their sources.
Inhibitors demonstrated effective binding to the SARS-CoV-2 main protease, suggesting strong potential for antiviral therapies.
Bicyclic peptides have emerged as promising inhibitors due to their high binding affinity and selectivity for target receptors. While peptide inhibitors are highly target-specific and exhibit strong protein-binding capabilities. However,...
No takes yet. Share an insight, caveat, or question.
Sharif et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: